Skip to content

Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03848884
Enrollment
34
Registered
2019-02-21
Start date
2019-03-01
Completion date
2019-10-16
Last updated
2019-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Patient

Brief summary

Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?

Detailed description

To evaluate if a monthly adherence monitoring and education service impacts the percent of patients adherent to oral diabetes and renin-angiotensin system antagonists (RASA) medications based on star ratings. It will also evaluate patient satisfaction of the adherence monitoring and education service, using a standard questionnaire.

Interventions

BEHAVIORALAdherence monitoring and education

Standardized medication counseling and education combined with individual patient customized guidance and counseling - administered monthly.

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years or older 2. Patients pre-identified by Kroger analytics in ClinicalQ - Patients with PDC \< 80% 3. Patient taking oral diabetes medications and/or RASA medications (ACE-I, ARB, direct renin inhibitor)

Exclusion criteria

1. Patients who are enrolled in MedSync or Autorefill program 2. Patients who are lost to follow-up 3. Incomplete/missing documentation of an encounter 4. Prisoners, children

Design outcomes

Primary

MeasureTime frameDescription
Adherence in oral diabetes medications determined by star ratingsBaseline to 6 monthsDetermine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.
Adherence in renin-angiotensin system antagonists (RASA) medications determined by star ratingsBaseline to 6 monthsDetermine change in patients who are adherent to RASA medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.

Secondary

MeasureTime frameDescription
Change in proportion of days covered (PDC)Baseline to 6 monthsDetermine change in PDC after monthly follow-up on medication adherence and education; pharmacy analytics determines patient PDC in normal practice. The mean PDC for each patient at the end of the six-month study period will be compared to the baseline using a student t-test.

Other

MeasureTime frameDescription
Satisfaction with education and monitoring service6 monthsPatient Satisfaction Survey includes an 8-item 5-point likert scale (Strongly Disagree, Disagree, Neutral, Agree, Strongly Agree) about whether or not the pharmacist provided adequate education to the patient, whether or not the patient feels his/her health benefited from the service, and if the patient would recommend the service. The Patient Satisfaction Survey will be analyzed using descriptive statistics to determine how satisfied patients were with the medication adherence monitoring and education service.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026